Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2017 (pdf):
download in single page format - double page (broad) format

Publication overview

Current news and events

Myeloma research funded by national clinical research program KLINBEFORSK

Fredrik Schjesvold

Fredrik Schjesvold, head of the Oslo Myeloma Center at Oslo University Hospital, receives 20 mill NOK from The national programme for clinical therapy research - KLINBEFORSK.
The supported project is entitled "The REMNANT study – Does early treatment of relapse increase survival in myeloma?" 
This is one of four projects coordinated from OUH receiving funding from KLINBEFORSK in 2018. The other three are headed by Michael Bretthauer, Guro Elisabeth Lind and Øyvind Molberg.

Award ceremony December 7thOslo University Hospital awards 6 excellent articles for the first half-year of 2018

Award winners during the ceremony.

In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly. 

Six research groups were awarded for their excellent papers published during the first half-year of 2018 on December 7th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.

International collaborative project led by Harald Stenmark supported with millions

Harald Stenmark (photo: Ola Sæther)

Harald Stenmark, head of the Cellular Membrane Dynamics group at the Department of Molecular Biology and the Center for Cancer Cell Reprogramming is the leader of one of 25 research projects receiving in total 100 million NOK from the Research Council of Norway and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (Diku), who together run the program INTPART. The aim is to strengthen collaborations with Brazil, Canada, India, Japan, China, Russia, South Africa and USA.
The project led by Stenmark now receiving support is the Chinese-Norwegian Partnership for Education and Research in Cancer Cell Biology (ChiNoCell). 

Kristin Bjordal "Researcher of the Month" for November 2018

Kristin Bjordal

Kristin Bjordal, head of "Research Support Services" unit at Oslo University Hospital and professor II the Institute of Clinical Medicine at the University of Oslo was appointed "Researcher of the Month" for November 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF).

Her research is presented in a feature article entitled "Cancer patients' quality of life should mean more for the choice of treatment".  "If a treatment allows the patient to live a little longer but the patient suffers a lot during the treatment period, this may not be the treatment we recommend", says Bjordal.

Units and subpages

View all subunitsHide all subunits